Kerstin B. Menander

782 total citations
19 papers, 582 citations indexed

About

Kerstin B. Menander is a scholar working on Oncology, Biotechnology and Immunology. According to data from OpenAlex, Kerstin B. Menander has authored 19 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Biotechnology and 6 papers in Immunology. Recurrent topics in Kerstin B. Menander's work include Cancer Research and Treatments (7 papers), Virus-based gene therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Kerstin B. Menander is often cited by papers focused on Cancer Research and Treatments (7 papers), Virus-based gene therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Kerstin B. Menander collaborates with scholars based in United States, United Kingdom and South Korea. Kerstin B. Menander's co-authors include D Langer, Karen Moline, Nancy Santilli, Fritz E. Dreifuss, Robert E. Sobol, Sunil Chada, John Nemunaitis, B. Falck, Patricia M. Davis and Joseph Shan and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Neurology.

In The Last Decade

Kerstin B. Menander

18 papers receiving 553 citations

Peers

Countries citing papers authored by Kerstin B. Menander

Since Specialization

Citations

This map shows the geographic impact of Kerstin B. Menander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin B. Menander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin B. Menander more than expected).

Fields of papers citing papers by Kerstin B. Menander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin B. Menander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin B. Menander. The network helps show where Kerstin B. Menander may publish in the future.

Co-authorship network of co-authors of Kerstin B. Menander

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin B. Menander. A scholar is included among the top collaborators of Kerstin B. Menander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin B. Menander. Kerstin B. Menander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Tumor suppressor immune gene therapy to reverse immunotherapy resistance 2021 ·Cancer Gene Therapy ·Sunil Chada, (unknown), Kerstin B. Menander, (unknown), Max W. Talbott, John Nemunaitis, Hyo Min Ahn, Bo‐Kyeong Jung, Chae‐Ok Yun, Robert E. Sobol	18
2	Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma 2021 ·Frontiers in Oncology ·Robert E. Sobol, Kerstin B. Menander, Sunil Chada, (unknown), (unknown), Max W. Talbott, John Nemunaitis	17
3	Reversing immune checkpoint inhibitor resistance with adenoviral IL-24 and p53 tumor suppressor immune gene therapy. 2018 ·Journal of Clinical Oncology ·Sunil Chada, (unknown), Kerstin B. Menander, (unknown), Eonju Oh, Chae‐Ok Yun, Robert E. Sobol	6
4	Effect of adenoviral p53 (Ad-p53) tumor suppressor immune gene therapy on checkpoint inhibitor resistance and abscopal therapeutic efficacy. 2017 ·Journal of Clinical Oncology ·Robert E. Sobol, Sunil Chada, (unknown), Chae‐Ok Yun, (unknown), Eonju Oh, Ravi Murthy, Vivek Subbiah, Kerstin B. Menander	4
5	Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non–Small-Cell Lung Cancer 2016 ·Clinical Lung Cancer ·David E. Gerber, David R. Spigel, (unknown), Mikhail Shtivelband, Olga Ponomarova, Joseph Shan, Kerstin B. Menander, Chandra P. Belani	16
6	Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment 2014 ·Journal for ImmunoTherapy of Cancer ·Adam C. Yopp, Nikoletta L. Kallinteris, Xianming Huang, (unknown), Kerstin B. Menander, Bruce Freimark, Jeff Hutchins, Steve King, Dmitry I. Gabrilovich, Rolf A. Brekken	1
7	Randomized, blinded, placebo-controlled phase II trial of docetaxel and bavituximab as second-line therapy in locally advanced or metastatic non-squamous non-small cell lung cancer. 2013 ·Journal of Clinical Oncology ·Mikhail Shtivelband, David R. Spigel, David E. Gerber, Minish Jain, Olga Ponomarova, (unknown), Joseph Shan, Kerstin B. Menander, Chandra P. Belani	10
8	Randomized, open-label, phase II trial of gemcitabine with or without bavituximab in patients with nonresectable stage IV pancreatic adenocarcinoma. 2013 ·Journal of Clinical Oncology ·Shuchi S. Pandya, Lucas Wong, Andrea J. Bullock, (unknown), (unknown), Joseph Shan, Kerstin B. Menander, Tony R. Reid	7
9	Abstract B34: A randomized open-label phase 2 trial of gemcitabine with or without bavituximab in patients with previously untreated stage IV pancreatic cancer. 2012 ·Shuchi S. Pandya, Lucas Wong, Tony R. Reid, (unknown), (unknown), Kerstin B. Menander, Joseph Shan	1
10	Immunotherapy of advanced melanoma by intratumoral injections of autologous, purified dendritic cells transduced with gene construct of interleukin-12, with dose-dependent expression under the control of an oral activator ligand. 2011 ·Journal of Clinical Oncology ·Douglas J. Schwartzentruber, John M. Kirkwood, Michael J. Guarino, Jon Richards, Oday Hamid, (unknown), John Nemunaitis, James E. Talmadge, Sunil Chada, Kerstin B. Menander, Kimberly Shafer-Weaver, (unknown), Mark Thornton, (unknown), R B Herberman	6
11	Development of human male meiosis in vitro 2009 ·Hereditas ·(unknown), A. Lima-de-Faria, Seth M. Rubin, Kerstin B. Menander	8
12	p53 therapy in a patient with Li-Fraumeni syndrome 2007 ·Molecular Cancer Therapeutics ·Neil Senzer, John Nemunaitis, Michael Nemunaitis, Jeffrey P. Lamont, Martin Gore, Hani Gabra, Rosalind A. Eeles, Nayanta Sodha, Frank J. Lynch, Louis A. Zumstein, Kerstin B. Menander, Robert E. Sobol, Sunil Chada	42
13	Tumor response criteria and biomarkers associated with increased survival following adenoviral p53 gene therapy (ADVEXIN) in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN) 2007 ·Journal of Clinical Oncology ·John Nemunaitis, Gary L. Clayman, John Hamm, Carol M. Bier‐Laning, Heikki Minn, David Van Echo, G. Yoo, Kerstin B. Menander, Robert E. Sobol, (unknown)	3
14	Phase II trial of patients (pts) with extensive stage small cell lung cancer (ES-SCLC) immunized with p53-transduced dendritic cells (p53-DC): Immune sensitization to chemotherapy (CT) 2007 ·Journal of Clinical Oncology ·Alberto Chiappori, Marco Sereno, Dmitry I. Gabrilovich, Noweeda Mirza, Mary Dunn, William E. Janssen, (unknown), Kerstin B. Menander, Sunil Chada, S. Antonia	3
15	Effective Combination of Cancer Vaccine With Chemotherapy in Patients With Extensive Stage Lung Cancer 2005 ·Journal of Immunotherapy ·Noweeda Mirza, Scott Antonia, Ingo Fricke, Alberto Chiappori, Patricia Thompson, Nicholas Williams, (unknown), George R. Simon, William E. Janssen, Kerstin B. Menander, Sunil Chada, Dmitry I. Gabrilovich	0
16	Valproic acid hepatic fatalities 1987 ·Neurology ·Fritz E. Dreifuss, Nancy Santilli, D Langer, (unknown), Karen Moline, Kerstin B. Menander	386
17	Compliance through the Use of Modern Dosage Forms 1986 ·Journal of Pharmacy Technology ·(unknown), Richard A. Levy, Kerstin B. Menander	5
18	Evidence of lack of abuse or dependence following pemoline treatment: Results of a retrospective survey 1986 ·Drug and Alcohol Dependence ·D Langer, (unknown), (unknown), Patricia M. Davis, Kerstin B. Menander	28
19	Androgen Secretion by the Rat Ovary 1962 ·Nature ·B. Falck, Kerstin B. Menander, (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact